Frank Wegmann
8Patents
2h-index
19Co-inventors
40Inventor score
Filing activity: Dec 15, 2016 → Dec 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11498944B2 | Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines | Chemistry; Metallurgy | 5 | Active |
| US10369214B2 | Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof | Chemistry; Metallurgy | 4 | Active |
| US11384122B2 | Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines | Chemistry; Metallurgy | 1 | Active |
| US11517618B2 | Method of inducing an immune response against human immunodeficiency virus by co-localized administration of vaccine components | Chemistry; Metallurgy | 0 | Active |
| US11229693B2 | Poxvirus vectors encoding HIV antigens, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11723970B2 | Poxvirus vectors encoding HIV antigens, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10973907B2 | Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens | Chemistry; Metallurgy | 0 | Active |
| US11896663B2 | Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.